May 19, 2026
The Trump administration’s slow-paced review of the abortion medication mifepristone has the attention of a U.S. Supreme Court justice, not just anti-abortion activists.
May 14, 2026
The U.S. Supreme Court on Thursday extended a stay preserving telehealth access to the abortion medication mifepristone while the Fifth Circuit weighs a challenge to the mail-order distribution of the pill.
May 12, 2026
The outcome of the latest abortion clash at the high court could reach well beyond mifepristone access and make other federal policy changes on hot-button or divisive issues more vulnerable to state challenges.
May 11, 2026
The U.S. Supreme Court on Monday extended a stay that preserved, for now, telehealth access to the abortion medication mifepristone.
May 07, 2026
The state of Louisiana on Thursday defended its standing to challenge telehealth access to the abortion medication mifepristone, telling the U.S. Supreme Court that it has suffered financial and other injuries as mail-order pills flood the state.
May 04, 2026
The U.S. Supreme Court on Monday temporarily reinstated telehealth access for the abortion medication mifepristone, pausing a lower-court order that had blocked by-mail and remote prescriptions.
May 01, 2026
The Fifth Circuit on Friday reinstated an in-person dispensing requirement for the abortion medication mifepristone, blocking mail-order access while a challenge to a Biden administration regulation brought by Louisiana officials moves forward.